Cambridge Healthtech Institute’s 6th Annual

Oligonucleotide Discovery and Delivery

Optimizing Design, Delivery and Performance

March 24, 2021

 

CHI’s Oligonucleotide Discovery and Delivery conference reveals the latest strategies at the forefront of discovery, chemistry and delivery with in-depth sessions on new chemistries, novel delivery mechanisms and the most important preclinical and clinical advances. Leading oligonucleotide scientists deliver detailed case studies on antisense, RNA, GalNAc, aptamers, conjugates and more – helping you develop the next generation of targeted oligonucleotide therapeutics.

 

Coverage will include, but is not limited to:

 

  • Discovery and delivery of COVID-19 mRNA vaccines
  • Developments from early discovery through to late-stage clinical programs
  • Adoption and implementation of innovative technologies used in discovery and delivery
  • Implementation of AI and machine learning in oligonucleotide design   
  • Examining the safety and toxicity of nucleic acid therapeutics
  • Strategic collaboration between big pharma and small biotechs
  • Advances in the following areas, including but not limited to: the CNS, the liver, inhalation drugs, immuno-oncology and ocular diseases

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is December 3, 2021.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:

Gemma Smith

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+44) 7754-518-131

Email: gsmith@cambridgeinnovationinstitute.com

 

For partnering and sponsorship information, please contact:

Shannon Kresge

Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-1343

Email: skresge@cambridgeinnovationinstitute.com